Diabetes,Tardive Dyskinesia,Parkinsonism,and Akathisia in Schizophrenia: A Retrospective Study Applying 1998 Diabetes Health Care Guidelines to Antipsychotic Use
Free accessBrief reportFirst published online June, 2004
Diabetes,Tardive Dyskinesia,Parkinsonism,and Akathisia in Schizophrenia: A Retrospective Study Applying 1998 Diabetes Health Care Guidelines to Antipsychotic Use
This study examines the links among diabetes, tardive dyskinesia (TD), and other extrapyramidal symptoms (EPS) in schizophrenia outpatients treated with typical and atypical antipsychotics.
Objectives:
Using a retrospective chart review, we compared 30 schizophrenia patients with diabetes mellitus (DM) with 30 schizophrenia patients, matched for age and sex, with no DM. We compared prevalence and severity of parkinsonism, akathisia, TD, dystonia, and antipsychotic type (that is, typical vs atypical).
Results:
We found no statistically significant differences between the DM group and the non-DM group prevalence and severity of EPS, including TD.
Conclusion:
We did not find DM and TD association to be significant in the era of atypical antipsychotics, possibly because of their antidyskinetic effect.
References
1.
GanziniLHeintzRTHoffmanWFCaseyDE. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. Arch Gen Psychiatry1991;48:259–63.
2.
WoernerMGSaltzBLKaneJMLiebermanJAAlvirJM. Diabetes and development of tardive dyskinesia. Am J Psychiatry1993;150:966–8.
3.
MukherjeeSWisniewskiABilderRSackeimHA. Possible association between tardive dyskinesia and altered carbohydrate metabolism. Arch Gen Psychiatry1985;42:205.
4.
MukherjeeSRothSDSandykRSchnurDB. Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance. Psychiatry Res1989;29:17–27.
5.
MukherjeeSMahadikS.Diabetes mellitus and tardive dyskinesia. In: YassaR, editor. Neuroleptic-induced movement disorders. New York: Cambridge University Press; 1997.
6.
SchultzSKArndtSHoBCOliverSEAndreasenNC. Impaired glucose tolerance and abnormal movements in patients with schizophrenia. Am J Psychiatry1999;156:640–2.
7.
JesteDVCaligiuriMPPaulsenJSHeatonRKLacroJPHarrisMJ, and others. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry1995;52:756–65.
8.
RajaMAzzoniA.Diabetes is not a risk factor for tardive dyskinesia: A retrospective observational study. Human Psychopharmacol2002;17:61–3.
9.
MeltzerSLeiterLDanemanDGersteinHCLauDLudwigS, and others. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ1998;159 (Suppl 8):S1–S29.
10.
ChouinardGRoss-ChouinardAAnnableLJonesB.The extrapyramidal symptom rating scale. Can J Neurol Sci1980;7:233.
11.
ChouinardG.Effects of risperidone in tardive dyskinesia: An analysis of the Canadian multicenter risperidone study. J Clin Psychopharmacol1995;15:36S–44S.
12.
LittrellKHJohnsonCGLittrellSPeabodyCD. Marked reduction of tardive dyskinesia with olanzapine. Arch Gen Psychiatry1998;55:279–80.
13.
TammingaCAThakerGKMoranMKakigiTGaoXM. Clozapine in tardive dyskinesia: Observations from human and animal model studies. J Clin Psychiatry1994;55(Suppl B):102–6.
14.
WszolaBANewellKMSpragueRL. Risk factors for tardive dyskinesia in a large population of youths and adults. Exp Clin Psychopharmacol2001;9:285–96.
15.
SernyakMJLeslieDLAlarconRDLosonczyMFRosenheckR.Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry2002;159:561–6.
KoroCEFedderDOL'ItalienGJWeissSMagderLSKreyenbuhlJ, and others. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. Arch Gen Psychiatry2002;59:1021–6.
18.
SobelMJaggersEDFranzMA. New-onset diabetes mellitus associated with the initiation of quetiapine treatment. J Clin Psychiatry1999;60:556–7.
19.
HendersonDCCaglieroEGrayCNasrallahRAHaydenDLSchoenfeldDAGoffDC. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry2000;157:975–81.
